文献速递衰弱、肌少症与跌倒老年综合评估老年慢病共病管理

基于常规实验室检查的衰弱指数可独立预测居家医疗启动患者的2年死亡风险

Frailty Index Based on Common Laboratory Tests for Patients Starting Home-Based Medical Care.
PubMed 文献 · J Am Med Dir Assoc · 2024-06-28

本研究为多中心前瞻性队列数据的二次分析,纳入188例在日本名古屋启动居家医疗服务的≥65岁患者,计算基于25项常规实验室参数的衰弱指数(FI-lab)和基于42项临床指标的衰弱指数(FI-clinical)。Cox回归显示FI-lab与2年死亡独立于FI-clinical相关(每0.1单位OR 1.49,95%CI 1.25-1.77),而FI-clinical无独立关联(OR 1.13,95%CI 0.90-1.41);两者均与住院或养老院入住无关。

要点

  • FI-lab每增加0.1单位,2年死亡风险独立增加49%(OR 1.49,95%CI 1.25-1.77)。
  • FI-clinical与2年死亡无独立关联(每0.1单位OR 1.13,95%CI 0.90-1.41)。
  • FI-lab和FI-clinical均与2年内住院或养老院入住无关。

核心结论

  • 在启动居家医疗服务的老年患者中,FI-lab与2年死亡独立于FI-clinical相关,可能有助于该人群的风险评估。

研究设计与样本

  • 多中心前瞻性队列研究的二次分析,纳入188例≥65岁在日本名古屋启动居家医疗服务的患者,平均年龄79.9±10.2岁,男性占57.5%。

主要发现

  • FI-lab中位数0.40(IQR 0.29-0.50),FI-clinical中位数0.32(IQR 0.24-0.43)。
  • Cox回归显示FI-lab与2年死亡独立相关(每0.1单位OR 1.49,95%CI 1.25-1.77),FI-clinical无独立关联(每0.1单位OR 1.13,95%CI 0.90-1.41)。
  • 1年死亡敏感性分析结果相似;FI-lab和FI-clinical均与2年内住院或养老院入住无关。

关键数值与推荐

  • FI-lab为25项常规实验室参数中异常结果的比例;FI-clinical基于42项临床指标计算。
  • 主要结局为启动居家医疗后2年内死亡;敏感性分析为1年死亡;其他结局包括2年内住院和养老院入住。

临床怎么用

  • 对启动居家医疗的老年患者,可计算FI-lab辅助识别2年死亡高风险个体,但需结合FI-clinical综合评估。
  • FI-lab和FI-clinical均不能预测2年内住院或养老院入住,临床决策不应仅依赖这些指数。

局限性

  • 样本量较小(188例),作者指出需要更大样本量的研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine whether a Frailty Index based on laboratory tests (FI-lab) is associated with clinical outcomes independently of a standard nonlaboratory Frailty Index (FI-clinical) in older patients starting home-based medical care. DESIGN: Secondary analysis of data from a multicenter prospective cohort study. SETTING AND PARTICIPANTS: Patients aged ≥65 years who were starting home-based medical care services provided by doctors and nurses at Nagoya, Japan. METHODS: We calculated FI-lab (proportion of abnormal results out of 25 commonly tested laboratory parameters) and FI-clinical using 42 items based on data obtained at enrollment. The primary outcome was mortality within 2 years after starting home-based medical care. A sensitivity analysis was also conducted with 1-year mortality as the outcome. Other outcomes included hospitalization and nursing home admission within 2 years. RESULTS: In total, 188 patients (mean age 79.9 ± 10.2 years, 57.5% male) were included. The median FI-lab was 0.40 [interquartile range (IQR) 0.29-0.50] and the median FI-clinical was 0.32 (IQR 0.24-0.43). Sixty-nine patients (36.7%) died within 2 years of starting home-based medical care. A Cox proportional hazards regression analysis including age, sex, FI-lab, and FI-clinical as independent variables revealed that FI-lab was associated with 2-year mortality independently of FI-clinical [FI-lab per 0.1 unit, odds ratio (OR) 1.49, 95% CI 1.25-1.77; FI-clinical per 0.1 unit, OR 1.13, 95% CI 0.90-1.41]. The sensitivity analysis showed similar results for 1-year mortality. Neither FI-lab nor FI-clinical was associated with hospitalization or nursing home admission within 2 years. CONCLUSIONS AND IMPLICATIONS: FI-lab was associated with 2-year mortality in patients starting home-based medical care, independently of FI-clinical, and may be useful for risk assessment in this population. Studies with larger sample sizes are needed.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Nakashima H, Watanabe K, Komiya H, et al. Frailty Index Based on Common Laboratory Tests for Patients Starting Home-Based Medical Care. J Am Med Dir Assoc. 2024. PMID: 38950586. doi:10.1016/j.jamda.2024.105114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。